Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus.
Stohl W, Hiepe F, Latinis KM, Thomas M, Scheinberg MA, Clarke A, Aranow C, Wellborne FR, Abud-Mendoza C, Hough DR, Pineda L, Migone TS, Zhong ZJ, Freimuth WW, Chatham WW; BLISS-52 Study Group; BLISS-76 Study Group.
Stohl W, et al. Among authors: migone ts.
Arthritis Rheum. 2012 Jul;64(7):2328-37. doi: 10.1002/art.34400.
Arthritis Rheum. 2012.
PMID: 22275291
Free PMC article.
Clinical Trial.